Linical Co., Ltd. (TYO:2183)
Japan flag Japan · Delayed Price · Currency is JPY
317.00
+3.00 (0.96%)
At close: Feb 6, 2026

Linical Company Description

Linical Co., Ltd., a global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide.

The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs, and licensing support.

It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management.

The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Linical Co., Ltd.
CountryJapan
Founded2005
IndustryBiotechnology
SectorHealthcare
Employees598
CEOKazuhiro Hatano

Contact Details

Address:
Shin-Osaka Brick Building
Osaka, 532-0003
Japan
Phone81 6 6150 2582
Websitelinical.com

Stock Details

Ticker Symbol2183
ExchangeTokyo Stock Exchange
Fiscal YearApril - March
Reporting CurrencyJPY
ISIN NumberJP3974530002
SIC Code8731

Key Executives

NamePosition
Kazuhiro HatanoChief Executive Officer